Nu Skin Enterprises Stock Forecast
NYSE: NUSHealth CareOther PharmaceuticalsUSD
Market open · Delayed 15 min · as of Oct 8, 1:40 PM ET
NUS analyst consensus
Consensus
none
Avg. price target
$12.77+167.15%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $12.77, with a high estimate of $12.77 and a low estimate of $12.77. The average target implies upside of 167.2% from the current price of $4.78. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NUS.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $12.77 | +167.15% |
| Average target | $12.77 | +167.15% |
| High target | $12.77 | +167.15% |
How analysts view Nu Skin Enterprises's peers
| Company | Consensus | Price | Avg. target | Implied move |
|---|---|---|---|---|
| HLF | none | 12.79 | $17.00 | +32.92% |